✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Lupin Ltd.

LUPIN

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹95,813 Cr.
P/E
22.16

Lupin Ltd.

  • Lupin
  • Zydus Lifesciences
  • Mankind Pharma
  • TJI Pharma

FAQs on Lupin Ltd. Shareprice

Lupin has given better returns compared to its competitors.
Lupin has grown at ~29.26% over the last 2yrs while peers have grown at a median rate of 8.05%

Lupin is not expensive.
Latest PE of Lupin is 22.16, while 3 year average PE is 56.81.
Also latest EV/EBITDA of Lupin is 14.61 while 3yr average is 32.82.

View FAQ's On Business

Growth Table

  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Balance Sheet

  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Cash Flow

  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Quarterly Results

  • Lupin Ltd.
  • Zydus Lifesciences
  • Mankind Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Lupin Ltd. Financials

Balance sheet of Lupin is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Lupin is increasing.
Latest net debt of Lupin is ₹2,738 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹1,185.51 Crs.

Yes, profit is increasing.
The profit of Lupin is ₹4,348 Crs for TTM, ₹3,282 Crs for Mar 2025 and ₹1,914 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lupin latest dividend payout ratio is 16.7% and 3yr average dividend payout ratio is 26.02%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech